BiomX
PHGE
13 hedge funds and large institutions have $1.15M invested in BiomX in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1% more capital invested
Capital invested by funds: $1.14M → $1.15M (+$11.5K)
0% more ownership
Funds ownership: 0.11% → 0.11% (+0%)
7% less funds holding
Funds holding: 14 → 13 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$53.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.55K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$3.09K |
| 5 |
Renaissance Technologies
New York
|
+$2.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$54K |
| 2 |
VF
Virtu Financial
New York
|
-$23K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$2.65K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $525K | – | – | – |
|
|
JJ
2
Johnson & Johnson
New Brunswick,
New Jersey
| $398K | – | – | – |
|
|
MI
3
MMCAP International
Grand Cayman,
Cayman Islands
| $128K | – | – | – |
|
|
4
Millennium Management
New York
| $51K | +$53.1K | +964 | +209% |
|
5
Jane Street
New York
| $11.2K | – | – | – |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| $9.24K | -$2.65K | -48 | -16% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7.73K | +$12K | +218 | New |
|
|
8
Renaissance Technologies
New York
| $7K | +$2.65K | +48 | +30% |
|
|
9
UBS Group
Zurich,
Switzerland
| $5.68K | +$7.55K | +137 | +685% |
|
10
Walleye Capital
New York
| $2.53K | – | – | – |
|
|
TSS
11
Two Sigma Securities
New York
| $1.98K | +$3.09K | +56 | New |
|
12
Walleye Trading
New York
| $1.95K | – | – | – |
|
13
BlackRock
New York
| $1.07K | – | – | – |
|
|
RA
14
Royce & Associates
New York
| – | -$54K | -835 | Closed |
|
|
VF
15
Virtu Financial
New York
| – | -$23K | -362 | Closed |
|
|
16
Citadel Advisors
Miami,
Florida
| – | -$11K | -168 | Closed |
|
PHGE Hedge Fund Activity: Q4 2022 in Review
13 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q4 2022, worth a combined $1.15M — up 1% from $1.14M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PHGE and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Millennium Management, adding an estimated $53.1K. The largest seller was Royce & Associates, exiting entirely with an estimated $54K sold.
- 13 institutional investors held BiomX (PHGE) as of Q4 2022, down from 14 in Q3 2022.
- Funds reported $1.15M of BiomX stock for Q4 2022, up 1% quarter-over-quarter.
- 2 funds opened new BiomX positions in Q4 2022 and 3 closed out, a net change of -1 holder.
- The largest BiomX buyer in Q4 2022 was Millennium Management, an estimated $53.1K added.
- The largest BiomX seller in Q4 2022 was Royce & Associates, an estimated $54K sold.
Based on aggregated 13F filings for Q4 2022.